Cargando…

中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342228/
https://www.ncbi.nlm.nih.gov/pubmed/31207711
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.05.016
_version_ 1783555411177111552
collection PubMed
description
format Online
Article
Text
id pubmed-7342228
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73422282020-07-16 中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2019-05 /pmc/articles/PMC7342228/ /pubmed/31207711 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.05.016 Text en 2019年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析
title 中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析
title_full 中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析
title_fullStr 中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析
title_full_unstemmed 中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析
title_short 中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析
title_sort 中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342228/
https://www.ncbi.nlm.nih.gov/pubmed/31207711
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.05.016
work_keys_str_mv AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī
AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī
AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī
AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī
AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī
AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī
AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī
AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī
AT zhōngdàjìliàngātángbāogāngǒnggùzhìliáoxìbāoyíchuánxuédīzhōngwēideniánqīngjíxìngsuǐxìbáixuèbìng124lìdānzhōngxīnhuígùxìngfēnxī